ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
-1.23%
S&P ASX All Technology
2,968.80
-1.53%
Brent Oil
84.78
-1.30%
US Dollar vs AUD
1.5439
-0.02%
Bitcoin
57,004.83
-5.93%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) News

RVMD Revolution Medicines Inc

37.28
0.00 (0.00%)
Pre Market
Last Updated: 18:44:51
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Revolution Medicines Inc RVMD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 37.28 18:44:51
Open Price Low Price High Price Close Price Previous Close
37.28
more quote information »

Recent News

Date Time Source Heading
10/4/202405:34GLOBERevolution Medicines Announces Publication on the Discovery..
09/4/202401:36GLOBERevolution Medicines Announces Publications on the Discovery..
05/4/202407:05GLOBERevolution Medicines to Participate in Upcoming Investor..
29/3/202407:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
06/3/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/2/202409:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202408:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
27/2/202408:04EDGAR2Form 8-K - Current report
21/2/202408:05GLOBERevolution Medicines to Report Financial Results for Fourth..
10/2/202409:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202408:05GLOBERevolution Medicines to Participate in Upcoming Investor..
25/1/202408:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202408:18EDGAR2Form 144 - Report of proposed sale of securities
10/1/202406:15EDGAR2Form 8-K - Current report
04/1/202423:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
21/12/202309:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202309:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202310:22EDGAR2Form 144 - Report of proposed sale of securities
15/12/202309:48EDGAR2Form 144 - Report of proposed sale of securities
21/11/202310:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202308:14EDGAR2Form 144 - Report of proposed sale of securities
17/11/202306:58EDGAR2Form CERT - Certification by an exchange approving..
16/11/202308:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
15/11/202312:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202312:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202312:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/11/202301:20EDGAR2Form 8-K - Current report
10/11/202301:10GLOBERevolution Medicines Completes Acquisition of EQRx
09/11/202303:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
07/11/202308:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
07/11/202308:05EDGAR2Form 8-K - Current report
01/11/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202322:11EDGAR2Form 425 - Prospectuses and communications, business..
01/11/202322:08EDGAR2Form 8-K - Current report
01/11/202322:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
01/11/202307:15GLOBERevolution Medicines to Report Financial Results for Third..
24/10/202309:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202321:13EDGAR2Form 425 - Prospectuses and communications, business..
23/10/202321:11EDGAR2Form 8-K - Current report
22/10/202317:30GLOBERevolution Medicines Presents Promising Clinical Activity..
14/10/202302:54EDGAR2Form 8-K - Current report
14/10/202302:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
05/10/202307:05GLOBERevolution Medicines to Present New Clinical Data at Major..
03/10/202307:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202306:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
30/9/202306:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Your Recent History

NASDAQ
RVMD
Revolution Medicines
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved